FDA Approves First Bispecific Antibody for Eyes
The U.S. Food and Drug Administration (FDA) recently approved Vabysmo (faricimab-svoa) for the treatment of neovascular or wet age-related macular…
The U.S. Food and Drug Administration (FDA) recently approved Vabysmo (faricimab-svoa) for the treatment of neovascular or wet age-related macular…
